Philips drives leadership in image-guided therapy solutions with launch of next generation Azurion platform

Sydney, Australia – Royal Philips (NYSE: PHG, AEX: PHIA), a leader in health technology, today announced the launch of Azurion, its next generation image guided therapy platform, which forms the new core of its integrated solutions portfolio for the fast-growing image guided therapy market. As a leader in this market, Philips offers integrated solutions comprising interventional imaging technologies and planning and navigation software combined with interventional devices - including catheters for diagnosis and therapy - and a broad range of services, all aimed at helping clinicians to provide superior care at predictable costs.

A leader in advanced catheters for diagnosis and therapy, following the acquisition of Volcano in 2015, Philips is now further cementing its position in image guided therapy. Philips’ Azurion image-guided therapy platform for interventional labs is the result of a multi-year, collaborative development program conducted with leading clinicians in the field. This next generation platform enables clinicians to swiftly and confidently perform a wide range of routine and complex procedures in the interventional lab.

“Philips’ vision is to provide seamlessly integrated solutions that advance minimally invasive procedures by helping physicians to decide, guide, treat and confirm the right therapy for reach patient at the point of care,” said Kevin Barrow, Managing Director, Philips Australia and New Zealand.

Azurion has been designed to address the industry challenges of controlling costs while maintaining their standards of care. The platform is equipped with new workflow options and performance dashboards, as well as an upcoming range of productivity improvement services. 

“Interventionalists are now expected to do more with less,” said Dr Atul Gupta, Chief Medical Officer Image Guided Therapy, Philips and Interventional Radiologist. “Over the last 20 years the profession has dramatically transformed. A growing and ageing population, in addition to lifestyle changes, now means the number and complexity of image guided procedures carried out in interventional labs has changed enormously; the technology needed to do the same,”. Azurion seeks to answer these issues and technologies like this will ultimately result in even less invasive procedures, fewer repeat procedures and improved workflow.”

The Azurion platform also features over 1,000 new components, which all work together to deliver high image quality at ultra-low X-ray dose and real-time image processing on multiple work spots within the interventional lab. Parallel working enables the team of clinicians to complete different tasks simultaneously in the interventional lab, saving valuable time without compromising quality of care. Azurion features procedure cards that allow clinicians to pre-program routine tasks and user preferences, helping to minimise preparation errors and further reducing preparation and procedure time.